Duke University School of Medicine, Durham, NC, USA.
Department of Orthopaedic Surgery, Duke University Hospital, Durham, NC, USA.
Ann Surg Oncol. 2021 Nov;28(12):7961-7972. doi: 10.1245/s10434-021-10099-7. Epub 2021 May 20.
There are limited data to inform risk of readmission and short-term mortality in musculoskeletal oncology. The goal of this study was to identify factors independently associated with 30-day readmission and 90-day mortality following surgical resection of osteosarcoma.
We retrospectively reviewed patients (n = 5293) following surgical resection of primary osteosarcoma in the National Cancer Database (2004-2015). Univariate and multivariate methods were used to correlate variables with readmission and short-term mortality.
Of 210 readmissions (3.97%), risk factors independently associated with unplanned 30-day readmission included comorbidity burden (odds ratio [OR] 2.4, p = 0.042), Medicare insurance (OR 1.9, p = 0.021), and axial skeleton location (OR 1.5, p = 0.029). A total of 91 patients died within 90 days of their surgery (1.84%). Risk factors independently associated with mortality included age (hazard ratio 1.1, p < 0.001), increasing comorbidity burden (OR 6.6, p = 0.001), higher grade (OR 1.7, p = 0.007), increasing tumor size (OR 2.2, p = 0.03), metastatic disease at presentation (OR 8.5, p < 0.001), and amputation (OR 2.0, p = 0.04). Chemotherapy was associated with a decreased risk of short-term mortality (p < 0.001).
Several trends were clear: insurance status, tumor location and comorbidity burden were independently associated with readmission rates, while age, amputation, grade, tumor size, metastatic disease, and comorbidity burden were independently associated with short-term mortality.
在肌肉骨骼肿瘤学中,有关再入院和短期死亡率的风险数据有限。本研究的目的是确定与骨肉瘤手术后 30 天再入院和 90 天死亡率相关的独立因素。
我们回顾性地分析了国家癌症数据库(2004-2015 年)中接受骨肉瘤手术切除的 5293 名患者的数据。使用单变量和多变量方法将变量与再入院和短期死亡率相关联。
210 例(3.97%)再入院中,与 30 天内非计划再入院独立相关的危险因素包括合并症负担(比值比 [OR] 2.4,p = 0.042)、医疗保险(OR 1.9,p = 0.021)和轴骨位置(OR 1.5,p = 0.029)。共有 91 例患者在手术后 90 天内死亡(1.84%)。与死亡率独立相关的危险因素包括年龄(风险比 1.1,p < 0.001)、合并症负担增加(OR 6.6,p = 0.001)、分级升高(OR 1.7,p = 0.007)、肿瘤大小增加(OR 2.2,p = 0.03)、初诊时存在转移疾病(OR 8.5,p < 0.001)和截肢(OR 2.0,p = 0.04)。化疗与短期死亡率降低相关(p < 0.001)。
有几个趋势很明显:保险状况、肿瘤位置和合并症负担与再入院率独立相关,而年龄、截肢、分级、肿瘤大小、转移疾病和合并症负担与短期死亡率独立相关。